Who's next in line for a PBS listing?

Posted 4 August 2022 AM

As PBS listings kicked off August, a raft of medicines simultaneously moved up the ladder becoming likely contenders for next month's entrants.

Exclusive Pharma in Focus analysis of drugs recommended from May 2021 to May 2022 shows 16 applications are sitting in the last stage of the listing process known as 'government processes', as of 1 August.

To see the whole article, please login

Popular

What Google says about PBS drugs

Next pegged blockbuster arrives

Is this drug the next Humira?

Who's moving to a new global HQ?

Latest Jobs

Legal Counsel & ERC Associate

Dedicated Principal Agent

Quality Control Analyst

Practice Development Manager

Territory Manager

See all...

Pharma in Focus Jobs

Marketing & Communications (3)

Sales & Customer Relations (20)

Clinical & Medical, R&D (14)

Regulatory, Pharmacovigilance & QA (6)

Devices (1)

Hospital Devices Account Manager - Sydney

Other (30)

MORE NEWS

Email this article to a friend

From:

Subject

Friend's email

Message to go with the article

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.

Skip password for now